PROPHYLAXIS OF ANAPHYLACTIC REACTIONS DURING BEE-VENOM IMMUNOTHERAPY BY BEE-VENOM IMMUNOGLOBULIN

被引：0
作者：
PRZYBILLA, B
RING, J
GALOSI, A
GEURSEN, RG
STICKL, HA
机构：
来源：
ALLERGOLOGIE | 1987年 / 10卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：308 / 311
页数：4
相关论文
共 50 条
  • [41] Microsphere entrapped bee-venom phospholipase A2 retains specific IgE binding capacity:: a possible use for oral specific immunotherapy
    Guérin, V
    Dubarry, M
    Robic, D
    Brachet, F
    Rautureau, M
    André, C
    Bourbouze, R
    Tomé, D
    [J]. JOURNAL OF MICROENCAPSULATION, 2002, 19 (06) : 761 - 765
  • [42] Release of mediators in patients with systemic anaphylactic reactions (SAR) due to immunotherapy (IT) with bee venom.
    Gniazdowska, B
    EberleinKonig, B
    Przybilla, B
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 608 - 608
  • [43] BIOENERGETIC ACTIONS OF BETA-BUNGAROTOXIN, DENDROTOXIN AND BEE-VENOM PHOSPHOLIPASE-A2 ON GUINEA-PIG SYNAPTOSOMES
    NICHOLLS, D
    SNELLING, R
    DOLLY, O
    [J]. BIOCHEMICAL JOURNAL, 1985, 229 (03) : 653 - 662
  • [44] ADVERSE REACTIONS AND MODIFICATIONS TO DOSING SCHEDULE DURING STANDARD BEE VENOM IMMUNOTHERAPY
    Ekstrom, Charlotta
    Salman, Sam
    Brusch, Anna
    [J]. INTERNAL MEDICINE JOURNAL, 2019, 49 : 19 - 19
  • [45] SUCCESSFUL EVALUATION OF AN IMMUNOTHERAPY WITH BEE VENOM
    URBANEK, R
    KUHN, W
    FORSTER, J
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 1984, 132 (09) : 700 - 700
  • [46] Mechanisms of immunotherapy to wasp and bee venom
    Ozdemir, C.
    Kucuksezer, U. C.
    Akdis, M.
    Akdis, C. A.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (09) : 1226 - 1234
  • [47] BEE VENOM IMMUNOTHERAPY AND BEE-STING MORTALITY IN AUSTRALIA
    FORD, RM
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1984, 140 (09) : 563 - 564
  • [48] Involvement of carbohydrate on phospholipase A2, a bee-venom allergen, in in vivo antigen-specific IgE synthesis in mice
    Okano, M
    Nishizaki, K
    Satoskar, AR
    Yoshino, T
    Masuda, Y
    Harn, DA
    [J]. ALLERGY, 1999, 54 (08) : 811 - 818
  • [49] To bee or not to bee: is omalizumab is the answer? Successful pretreatment with omalizumab in bee venom immunotherapy
    Pereira, A. M.
    Coimbra, A.
    Reis Ferreira, A.
    Fonseca, J. A.
    [J]. ALLERGY, 2014, 69 : 399 - 399
  • [50] SUBCLASS OF IGG ANTI-BEE VENOM ANTIBODY PRODUCED DURING BEE VENOM IMMUNOTHERAPY AND ITS RELATIONSHIP TO LONG-TERM PROTECTION FROM BEE STINGS AND FOLLOWING TERMINATION OF VENOM IMMUNOTHERAPY
    URBANEK, R
    KEMENY, DM
    RICHARDS, D
    [J]. CLINICAL ALLERGY, 1986, 16 (04): : 317 - 322
12345